TD-6450 SAD and MAD in Healthy Subjects

NCT02022306 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: TD-6450
DRUG: Placebo

Sponsor

Theravance Biopharma